Latent Class Analysis Identifies Distinctive Behavioral Subtypes in Children with Fragile X Syndrome.
Walter E Kaufmann, Melissa Raspa, Carla M Bann and 4 others
PMID 36441429WHAT IT FOUND
Children with fragile X syndrome fall into five distinct behavioral groups.
Three moderate-severity groups differ clearly: one with high anxiety and social avoidance, one with disruptive behaviors, and one with attention issues but less social impairment. This helps target support.
Key findings
01A five-class model identified distinct behavioral subtypes: Mild, Severe, and three Moderate groups (Moderate without Social Impairment, Moderate with Social Impairment, Moderate with Disruptive Behavior).
02The Moderate with Social Impairment group had the highest rates of anxiety and social avoidance scores, and a higher proportion of females, suggesting social anxiety rather than just autism.
03The Moderate with Disruptive Behavior group had the highest rates of ADHD-like symptoms, irritability/aggression, and sensory/sleep problems, resembling the Severe group but with lower rates of severe intellectual disability.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTsWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study is cross-sectional, so it cannot show how stable these subtypes are over time or predict future outcomes. Data came from a clinic-based sample, which may not represent all children with Fragile X syndrome, especially those not receiving specialized care. Some measures, particularly for sensory and sleep problems, were ad hoc clinician reports rather than standardized instruments, which may affect reproducibility. The sample was exclusively pediatric, so the findings do not apply to adults with Fragile X syndrome. The study identified subtypes based on current behavior but did not link them to specific neurobiological markers or genetic variations like mosaicism.
Declared interests
One author is a Chief Scientific Officer of a biotech company. Others have been investigators or consultants for pharmaceutical companies (Ionis, Neuren, Ovid, Zynerba) that develop treatments for Fragile X syndrome. The study itself was funded by the FORWARD project, which is supported by the Fragile X Alliance and other foundations.
The easy way to misread this
Do not assume these subtypes are fixed lifelong categories or that they have distinct biological causes. The study is cross-sectional and clinic-based, so it describes current behavioral patterns in children receiving care, not necessarily stable traits or underlying neurobiology.